ArticleFrontiers in artificial intelligence2025
Enhancing one-year mortality prediction in STEMI patients post-PCI: an interpretable machine learning model with risk stratification.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A fine-grained transformer combined with multimodal data for predicting hospital length of stay in acute coronary syndrome.Scientific reports · 2026Article
- Development and validation of an in-hospital cardiogenic shock prediction model for AMI patients based on machine learning.BMC cardiovascular disorders · 2026Article
- Machine learning redevelopment of GRACE, ACEF, and TIMI scores for 6-month mortality.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: ST-elevation myocardial infarction (STEMI) poses a significant threat to global mortality and disability. Advances in percutaneous coronary intervention (PCI) have reduced in-hospital mortality, highlighting the importance of post-discharge management. Machine learning (ML) models have shown promise in predicting adverse clinical outcomes. However, a systematic approach that combines high predictive accuracy with model simplicity is still lacking. Methods: This retrospective study applied three data processing and ML algorithms to address class imbalance and support model development. ML models were trained to predict one-year mortality in STEMI patients post-PCI, with performance evaluated using accuracy, sensitivity, precision, F1-score, area under the receiver operating characteristic curve (AUROC), and the area under the precision-recall curve (AUPRC). Results: We analyzed data from 1,274 patients, incorporating 46 clinical and laboratory features. Using the Random Forest (RF) algorithm, we achieved an AUROC of 0.94 (95% confidence interval (CI): 0.90-0.98), an AUPRC of 0.44 (95% CI:0.15-0.76) in the internal validation set, identifying five key predictors: cardiogenic shock, creatinine, NT-proBNP, diastolic blood pressure, and left ventricular ejection fraction. By integrating risk stratification, the model's performance improved, achieving an AUROC of 0.97 (95% CI: 0.96-0.99) and an AUPRC of 0.74 (95% CI: 0.60-0.84). Conclusion: This study highlights the feasibility of constructing accurate and interpretable ML models using a minimal set of predictors, supplemented by risk stratification, to improve long-term outcome prediction in STEMI patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.